Page 254 - EJMO-9-2
P. 254

Eurasian Journal of
            Medicine and Oncology                                                   Prognosis of colon adenocarcinoma



            References                                            survival in colorectal cancer. Front Oncol. 2020;10:595.

            1.   Sung H, Ferlay J, Siegel RL,  et al. Global cancer statistics      doi: 10.3389/fonc.2020.00595
               2020: GLOBOCAN estimates of incidence and mortality   13.  Mo X, Huang X, Feng Y,  et al. Immune infiltration
               worldwide for 36 cancers in 185 countries. CA Cancer J Clin.   and immune gene signature predict the response to
               2021;71(3):209-249.                                fluoropyrimidine-based chemotherapy in colorectal cancer
               doi: 10.3322/caac.21660                            patients. Oncoimmunology. 2020;9(1):1832347.
            2.   Wang  H, Liu J,  Li  J,  et al.  Identification of  gene  modules      doi: 10.1080/2162402X.2020
               and hub genes in colon adenocarcinoma associated with   14.  Miao YD, Wang JT, Yang Y, et al. Identification of prognosis-
               pathological  stage  based  on WGCNA  analysis.  Cancer   associated immune genes and exploration of immune.
               Genet. 2020;242:1-7.                               Biomark Med. 2020;14(14):1353-1369.
               doi: 10.1016/j.cancergen.2020.01.05                doi: 10.2217/bmm-2020-0024
            3.   Aaltonen LA. The multistep process of colon carcinogenesis.   15.  Cucchiara V, Cooperberg MR, Dall’Era M, et al. Genomic
               Cytokines Mol Ther. 1996;2(2):111-114.             Markers in Prostate Cancer Decision Making.  Eur Urol.
            4.   Miller KD, Nogueira L, Mariotto AB, et al. Cancer treatment   2018;73(4):572-582.
               and survivorship statistics, 2019.  CA Cancer J Clin.      doi: 10.1016/j.eururo.2017.10.036
               2019;69(5):363-385.
                                                               16.  Chen XF, Tian MX, Sun RQ, et al. SIRT5 inhibits peroxisomal
               doi: 10.3322/caac.21565                            ACOX1 to prevent oxidative damage and is downregulated
            5.   Arnold M, Abnet CC, Neale RE, et al. Global burden of 5   in liver cancer. EMBO Rep. 2018;19(5):e45124.
               major types of gastrointestinal cancer.  Gastroenterology.      doi: 10.15252/embr.201745124
               2020;159(1):335-349.e15.
                                                               17.  Sun LN, Zhi Z, Chen LY, et al. SIRT1 suppresses colorectal
               doi: 10.1053/j.gastro.2020.02.068                  cancer metastasis by transcriptional repression of mir-
            6.   Oberndorfer F, Moling S, Hagelkruys LA,  et al. Risk   15b-5p. Cancer Lett. 2017;409:104-115.
               reclassification of patients with endometrial cancer based on      doi: 10.1016/j.canlet.2017.09.001
               tumor molecular profiling: First real world data. J Pers Med.
               2021;11(1):48.                                  18.  Deng L, Niu GM, Ren J, Ke CW. Identification of ATP8B1
                                                                  as a tumor suppressor  gene for colorectal  cancer and  its
               doi: 10.3390/jpm11010048                           involvement in phospholipid homeostasis. Biomed Res Int.
            7.   Langfelder P, Horvath S. WGCNA: An R package for   2020;2020:2015648.
               weighted correlation network analysis.  BMC Bioinform.      doi: 10.1155/2020/2015648
               2008;9:559.
                                                               19.  Liu L, Yang J, Wang C. Analysis of the prognostic significance
               doi: 10.1186/1471-2105-9-559                       of solute carrier (SLC) family 39 genes in breast cancer.
            8.   Tu J, Kuang Z, Xie X, et al. Prognostic and predictive value of   Biosci Rep. 2020;40(8):BSR20200764.
               a mRNA signature in peripheral T-cell lymphomas: A mRNA      doi: 10.1042/BSR20200764
               expression analysis. J Cell Mol Med. 2021;25(1):84-95.
                                                               20.  Shao Y, Jia H, Huang L,  et al. An original ferroptosis-
               doi: 10.1111/jcmm.15851                            related gene signature effectively predicts the prognosis and
            9.   Marisa L, De Reyniès A, Duval A, et al. Gene expression   clinical status for colorectal cancer patients.  Front Oncol.
               classification of colon cancer into molecular subtypes:   2021;11:711776.
               Characterization, validation, and prognostic value.  PLoS      doi: 10.3389/fonc.2021.711776
               Med. 2013;10(5):e1001453.
                                                               21.  Wang R, Ma Y, Zhan S, et al. B7-H3 promotes colorectal
               doi: 10.1371/journal.pmed.1001453
                                                                  cancer angiogenesis through activating the NF-Κb pathway
            10.  Clough E, Barrett T. The gene expression omnibus database.   to induce VEGFA expression. Cell Death Dis. 2020;11(1):55.
               Methods Mol Biol. 2016;1418:93-110.
                                                                  doi: 10.1038/s41419-020-2252-3
               doi: 10.1007/978-1-4939-3578-9-5
                                                               22.  Han J, Zhang X, Liu Y, Jing L, Liu YB, Feng L. CLCA4 and
            11.  Flicek P, Amode MR, Barrell D, et al. Ensembl 2011. Nucleic   MS4A12 as the significant gene biomarkers of primary
               Acids Res. 2011;39(S 1):D800-D806.                 colorectal cancer. Biosci Rep. 2020;40(8):BSR20200963.
               doi: 10.1093/nar/gkq1064                           doi: 10.1042/BSR20200963
            12.  Yuan Y, Chen J, Wang J,  et al. Development and clinical   23.  Wang HW, Duan ZJ, Hu SS, Wang S. Expression of cAMP-
               validation of a novel 4-gene prognostic signature predicting   dependent protein kinase inhibitor beta in colorectal


            Volume 9 Issue 2 (2025)                        246                         doi: 10.36922/EJMO025060024
   249   250   251   252   253   254   255   256   257   258   259